ProKidney Corp. Profile Avatar - Palmy Investing

ProKidney Corp.

ProKidney Corp., a clinical-stage biotechnology, engages in developing cellular therapy candidates. It is developing Renal Autologous Cell Therapy, an autologous homologous cell admixture that is in a Phase III development program, as well as Phase II cl…

Biotechnology
US, Winston-Salem [HQ]
Government, Law & Regulation

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

ProKidney Corp. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
0.0 IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
YoY Trends
  • No trends presentable at the moment.

Spending By Type

Awards
Obligations
Contracts IDV Contracts Grants Loans Direct Other

ProKidney Corp. can't present spending by time.

Contract Analysis

There are no contract award details available for ProKidney Corp.

End of PROK's Analysis
CIK: 1850270 CUSIP: - ISIN: KYG7S53R1049 LEI: - UEI: -
Secondary Listings
PROK has no secondary listings inside our databases.